Skip to Content

Posts tagged with "Academia (vs. Industry)"

  • Academia (vs. Industry)

    Does Anyone Want the NIH’s Drug Screening Program?

    Science is reporting some problems with the NIH’s drug screening efforts: A $70-million-a-year program launched 7 years ago at the National Institutes of Health (NIH) to help academic researchers move into industry-style drug discovery may soon be forced to scale back sharply. NIH Director Francis Collins has been one of its biggest champions… Read More
  • Academia (vs. Industry)

    “The Smarter You Are, The More I Will Hate You”

    I have just enough time today to link to this – which is simultaneously a nasty prank to pull on someone, and (for anyone who’s been to grad school), completely hilarious. A message went out over a mail server list in Europe, after a post-doc position in Germany had been posted. It, um, clarified the… Read More
  • Academia (vs. Industry)

    Publishing, Perishing, Buying and Selling

    Here’s another article in the Guardian that makes some very good points about the way we judge scientific productivity by published papers. My favorite line of all: “To have “written” 800 papers is regarded as something to boast about rather than being rather shameful.” I couldn’t have put it better, and I couldn… Read More
  • Academia (vs. Industry)

    How Many New Drug Targets Aren’t Even Real?

    So, are half the interesting new results in the medical/biology/med-chem literature impossible to reproduce? I linked earlier this year to an informal estimate from venture capitalist Bruce Booth, who said that this was his (and others’) experience in the business. Now comes a new study from Bayer Pharmaceuticals that helps put some backing b… Read More
  • Academia (vs. Industry)

    Broader Impacts Indeed

    Since I don’t have to write NSF grants, I haven’t had to wrestle with “Criterion 2”. But ask anyone in academic science about it. The first criterion is intellectual merit, as it darn well should be. Here’s the NSF’s own description (in full): How important is the proposed activity to advancing knowledge and unde… Read More
  • Academia (vs. Industry)

    The NIH and Conflicts of Interest

    The NIH has, it appears, been getting quite sensitive about conflicts of interest. There have been some rather ugly scenes involving ghostwritten articles (and entire books), and NIH director Francis Collins has said that the agency’s guidelines are in the process of being revised. You’d have thought that the existing ones would have ba… Read More
  • Academia (vs. Industry)

    What Translational Research Should Academia Do?

    We’ve talked quite a bit around here about academic (and nonindustrial) drug discovery, but those posts have mostly divided into two parts. There’s the early-stage discovery work that really gets done in some places, and then there’s the proposal for the big push into translational research by the NIH. That, broadly defined, is (a… Read More
  • Academia (vs. Industry)

    Academic Drug Discovery: A Survey

    Nature Reviews Drug Discovery has an interesting survey of academic drug discovery (summary at SciBx here). The authors were motivated, they say, by the large number of opinions and impressions about this topic, with a corresponding lack of actual data – I think they’ve done everyone a service. What they found was 78 centers of… Read More
  • Academia (vs. Industry)

    Roche Prevails Over Stanford

    The Supreme Court has ruled on the Roche – Stanford case that I blogged about here. In short, the dispute centered on the Bayh-Dole act (on commercializing academic research) and sought to clarify under what circumstances university collaborators signed over the rights to their discoveries. (That makes the case sound quite calm and removed fr… Read More
  • Academia (vs. Industry)

    Maybe It Really Is That Hard?

    Here’s an interesting note from the Wall Street Journal‘s Health Blog. I can’t summarize it any better than they have: “When former NIH head Elias Zerhouni ran the $30 billion federal research institute, he pushed for so-called translational research in which findings from basic lab research would be used to develop medicine… Read More
...789...